New technologies to prevent intravascular catheter-related bloodstream infections.
Most intravascular catheter-related infections are associated with central venous catheters. Technologic advances shown to reduce the risk for these infections include a catheter hub containing an iodinated alcohol solution, short-term chlorhexidine-silver sulfadiazine- impregnated catheters, minocycline-rifampin-impregnated catheters, and chlorhexidine- impregnated sponge dressings. Nontechnologic strategies for reducing risk include maximal barrier precautions during catheter insertion, specialized nursing teams, continuing quality improvement programs, and tunneling of short-term internal jugular catheters.
Mermel
L A
LA
Brown University School of Medicine and Rhode Island Hospital, Providence, Rhode Island, USA. lmermel@lifespan.org
D000438:Alcohols; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002710:Chlorhexidine; D004202:Disinfectants; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007454:Iodides; D008911:Minocycline; D012293:Rifampin; D018805:Sepsis / Q000517:prevention & control*; D012837:Silver Sulfadiazine
D000438:Alcohols; D004202:Disinfectants; D007454:Iodides; D008911:Minocycline; D002710:Chlorhexidine; D012293:Rifampin; D012837:Silver Sulfadiazine